The Pharmaceutical Journal
Vol 279 No 7478 p556
17 November 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Anti-cancer virus

Researchers have engineered a tumour-selective poxvirus with systemic activity against cancer cells (Journal of Clinical Investigation 2007;117:3350).

JX-963 displayed rapid and potent anti-tumour effects when tested in rabbits with primary liver tumours and lung metastases.